Explore Goldman Sachs' top 5 Indian pharma stock picks with up to 36% upside - see the full recommendations now!

The Name of the Sister begins in classic genre territory: a young woman is found stumbling down an outback road, without the ...

Did you ever notice how the weather sneaks into our everyday conversations—and even our history? U.S. Presidents, standing at ...

SOL jumps 7.9% to $156.53 as Bybit announces Solana-based DEX 'Byreal' for Q3 2025 launch with unified liquidity and ...

Robert Kaplan’s latest book on big geopolitical questions reflects a shift away from high-minded ideals in US establishment thought. But instead of self-critical pragmatism, what he offers as a ...

Vir Biotechnology's Chief Executive Officer, Marianne De Backer, expressed optimism about the preliminary safety and efficacy data, ... Any buy, sell, or other recommendations mentioned in the article ...

Organizational optimism similarly fell, from 50% last quarter to 37% of executives optimistic about their own company prospects. Domestic economic conditions supplanted inflation as the top challenge.